Biofrontera (BFRIW) Current Assets (2020 - 2025)

Biofrontera's Current Assets history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• In Q4 2025, Current Assets fell 12.64% year-over-year to $18.1 million; the TTM figure through Dec 2025 stood at $18.1 million (down 12.64% YoY), while the FY2025 annual figure was $18.1 million, down 12.64% from the prior year.
• Current Assets was $18.1 million for Q4 2025 at Biofrontera, up from $14.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $48.5 million in Q3 2022 to a low of $10.1 million in Q3 2021.
• Historically, Current Assets has averaged $27.6 million across 5 years, with a median of $20.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Assets surged 378.38% in 2022, then slumped 46.51% in 2023.
• A 5-year view of Current Assets shows it stood at $46.4 million in 2021, then dropped by 7.07% to $43.1 million in 2022, then plunged by 46.51% to $23.1 million in 2023, then retreated by 10.29% to $20.7 million in 2024, then dropped by 12.64% to $18.1 million in 2025.
• The last three Current Assets figures came in at $18.1 million (Q4 2025), $14.4 million (Q3 2025), and $18.8 million (Q2 2025), per Business Quant data.